461 related articles for article (PubMed ID: 19200574)
21. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
[TBL] [Abstract][Full Text] [Related]
22. [Clinical features and prognosis of nasal type NK/T cell lymphoma].
Zhang YJ; Hu WH; Liu H; Cheng EC; Ren ZM; Xia YF; Cui NJ
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):50-3. PubMed ID: 16737622
[TBL] [Abstract][Full Text] [Related]
23. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
[TBL] [Abstract][Full Text] [Related]
24. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.
Lee J; Suh C; Park YH; Ko YH; Bang SM; Lee JH; Lee DH; Huh J; Oh SY; Kwon HC; Kim HJ; Lee SI; Kim JH; Park J; Oh SJ; Kim K; Jung C; Park K; Kim WS
J Clin Oncol; 2006 Feb; 24(4):612-8. PubMed ID: 16380410
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
26. Primary bony peripheral T-cell lymphoma mimicking nasal type NK/T-cell lymphoma: a case report.
Chuang SS; Lin CN; Li CY
Pathol Res Pract; 2002; 198(5):369-73. PubMed ID: 12092774
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.
Li YX; Yao B; Jin J; Wang WH; Liu YP; Song YW; Wang SL; Liu XF; Zhou LQ; He XH; Lu N; Yu ZH
J Clin Oncol; 2006 Jan; 24(1):181-9. PubMed ID: 16382127
[TBL] [Abstract][Full Text] [Related]
28. Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters.
Isobe K; Uno T; Tamaru J; Kawakami H; Ueno N; Wakita H; Okada J; Itami J; Ito H
Cancer; 2006 Feb; 106(3):609-15. PubMed ID: 16369986
[TBL] [Abstract][Full Text] [Related]
29. [Study of the pathology, immunophenotype, etiology and genetic marker of NK/T-cell lymphoma].
Zhong BN; Zhang XH; Li M; Cao HG; Li N; Liu CY; Gu YQ; Gao ZF
Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):505-9. PubMed ID: 14690577
[TBL] [Abstract][Full Text] [Related]
30. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma.
Lozzi GP; Massone C; Citarella L; Kerl H; Cerroni L
Am J Dermatopathol; 2006 Feb; 28(1):9-12. PubMed ID: 16456318
[TBL] [Abstract][Full Text] [Related]
31. Intravascular large T-cell or NK-cell lymphoma: a rare variant of intravascular large cell lymphoma with frequent cytotoxic phenotype and association with Epstein-Barr virus infection.
Cerroni L; Massone C; Kutzner H; Mentzel T; Umbert P; Kerl H
Am J Surg Pathol; 2008 Jun; 32(6):891-8. PubMed ID: 18425045
[TBL] [Abstract][Full Text] [Related]
32. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous dissemination of nasal NK/T-cell lymphoma in a young girl.
Sandner A; Helmbold P; Winkler M; Gattenlöhner S; Müller-Hermelink HK; Holzhausen HJ
Clin Exp Dermatol; 2008 Aug; 33(5):615-8. PubMed ID: 18616730
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Shim SJ; Yang WI; Shin E; Koom WS; Kim YB; Cho JH; Suh CO; Kim JH; Kim GE
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):31-8. PubMed ID: 17049184
[TBL] [Abstract][Full Text] [Related]
35. Extranodal natural killer cell/t-cell lymphoma, nasal type, presenting as cutaneous nodules and a small-bowel perforation.
Agarwal P; Ruzinova MB; Harris MH; Qureshi AA; Stebbins WG
Am J Dermatopathol; 2010 Feb; 32(1):83-5. PubMed ID: 19940752
[TBL] [Abstract][Full Text] [Related]
36. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
[TBL] [Abstract][Full Text] [Related]
37. Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases.
Bittencourt AL; Barbosa HS; Vieira MD; Farré L
Acta Oncol; 2009; 48(4):598-604. PubMed ID: 19165640
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathology, immunophenotype, T cell receptor gene rearrangement, Epstein-Barr virus status and p53 gene mutation of cutaneous extranodal NK/T-cell lymphoma, nasal-type.
Wang TT; Xu C; Liu SL; Kan B; Ran YP; Liu WP; Li GD; Wang L
Chin Med J (Engl); 2013 Apr; 126(7):1281-7. PubMed ID: 23557559
[TBL] [Abstract][Full Text] [Related]
39. Extranodal NK/T-cell lymphoma, nasal type, arising in association with saline breast implant: expanding the spectrum of breast implant-associated lymphomas.
Aladily TN; Nathwani BN; Miranda RN; Kansal R; Yin CC; Protzel R; Takowsky GS; Medeiros LJ
Am J Surg Pathol; 2012 Nov; 36(11):1729-34. PubMed ID: 23073330
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]